A
Akari Therapeutics plc D
D
AKTX
1.19000
USD
0.09
(8.18%)
قبل الجلسة
حجم التداول
58
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
31,501,632
الأخبار المقالات
العنوان: Akari Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).